An irregular heartbeat (known as atrial fibrillation or AF) is a stronger risk factor for stroke, heart disease, heart failure and death in women than in men, although the cause is unclear, finds a study in The BMJ this week.
Jan 19, 2016
0
2
(HealthDay)—Portrazza (necitumumab), in combination with two other chemotherapy drugs, has been approved by the U.S. Food and Drug Administration to treat advanced squamous non-small cell lung cancer, the agency said Tuesday ...
Nov 25, 2015
0
3
For the first time, joint recommendations may permit participation in competitive sports for some athletes diagnosed with a specific type of irregular heartbeat and for others who have an implanted medical device that regulates ...
Nov 2, 2015
0
43
Federal health regulators have approved a drug to reverse the blood-thinning effects of the popular pill Pradaxa, which has been subject to thousands of reports of severe bleeding.
Oct 16, 2015
0
18
There is no association between coffee consumption and an increased risk of atrial fibrillation, according to research published in the open access journal BMC Medicine. The research includes a meta-analysis of four other ...
Sep 22, 2015
0
158
Certain commonly prescribed anti-nausea medications given to patients during or after an operation could increase their risk of developing an irregular heartbeat, new research has found.
Jun 18, 2015
0
19
For the first time, scientists can efficiently generate large numbers of rare cells in the network that pushes the heart's chambers to consistently contract. The technique, published May 28 in Stem Cell Reports, could be ...
Jun 2, 2015
0
313
Chronic obstructive pulmonary disease, or COPD, is associated with increased risk of dying from a cardiovascular disease such as heart failure or a heart attack, as well as diseases not associated with the heart. However, ...
May 20, 2015
0
15
In research published today in the journal Cerebral Cortex, a team of scientists led by the University of Cambridge and the Medical Research Council (MRC) Cognition and Brain Sciences Unit, Cambridge, studied not only whether ...
Apr 20, 2015
0
158
(HealthDay)—Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure, the agency said in a news release.
Apr 17, 2015
0
3
